文献速递心力衰竭与心肌病心律失常

LMNA基因突变致心肌病:年轻发病、高外显率且常需心脏移植

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
PubMed 文献 · Eur Heart J · 2018-01-01

在挪威家族性扩张型心肌病患者中,LMNA突变患病率为6.2%;无症状LMNA基因阳性家属年心脏表型发生率为9%,随访期间心脏外显率达61%;79例LMNA患者中19%需心脏移植。

要点

  • 家族性DCM先证者中LMNA突变患病率为6.2%。
  • 无症状LMNA阳性家属年心脏表型发生率9%,随访外显率61%。
  • 79例LMNA患者中19%接受心脏移植。

核心结论

  • LMNA突变在挪威家族性DCM中患病率为6.2%。
  • 无症状年轻LMNA基因阳性家属心脏外显率高,常见房室阻滞和室性心动过速。
  • 近20%的LMNA患者需要心脏移植。

研究设计与样本

  • 2003-15年对转诊的家族性DCM患者进行基因检测。
  • 对LMNA基因阳性者行心电图、动态心电图、心脏磁共振和超声心动图检查。
  • 共纳入561例无亲缘关系的家族性DCM先证者,其中35例(6.2%)有LMNA突变。
  • 家族筛查额外诊断93例LMNA基因阳性家属。
  • 临床随访79例LMNA基因阳性者(年龄42±16岁,EF 45±13%),其中44例(56%)有VT。

主要发现

  • 无症状LMNA基因阳性家属(年龄31±15岁)年心脏表型发生率为9%。
  • 随访4.4±2.9年期间,心脏外显率为61%(19/31)。
  • 79例LMNA患者在随访7.8±6.3年期间,15例(19%)接受了心脏移植。

关键数值与推荐

  • 心脏阳性表型定义为存在房室阻滞、心房颤动/扑动、室性心动过速和/或超声心动图诊断的DCM。

临床怎么用

  • 对家族性DCM先证者应进行LMNA基因检测。
  • 对LMNA基因阳性家属应早期筛查并定期心脏随访。
  • LMNA患者需评估房室阻滞、房性心律失常和室性心动过速风险。
  • LMNA患者应评估心脏移植需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Lamin A/C (LMNA) mutations cause familial dilated cardiomyopathy (DCM) with frequent conduction blocks and arrhythmias. We explored the prevalence, cardiac penetrance, and expressivity of LMNA mutations among familial DCM in Norway. Furthermore, we explored the risk factors and the outcomes in LMNA patients. METHODS AND RESULTS: During 2003-15, genetic testing was performed in patients referred for familial DCM. LMNA genotype-positive subjects were examined by electrocardiography, Holter monitoring, cardiac magnetic resonance imaging, and echocardiography. A positive cardiac phenotype was defined as the presence of atrioventricular (AV) block, atrial fibrillation/flutter (AF), ventricular tachycardia (VT), and/or echocardiographic DCM. Heart transplantation was recorded and compared with non-ischaemic DCM of other origin. Of 561 unrelated familial DCM probands, 35 (6.2%) had an LMNA mutation. Family screening diagnosed an additional 93 LMNA genotype-positive family members. We clinically followed up 79 LMNA genotype-positive [age 42 ± 16 years, ejection fraction (EF) 45 ± 13%], including 44 (56%) with VT. Asymptomatic LMNA genotype-positive family members (age 31 ± 15 years) had a 9% annual incidence of a newly documented cardiac phenotype and 61% (19/31) of cardiac penetrance during 4.4 ± 2.9 years of follow-up. Ten (32%) had AV block, 7 (23%) AF, and 12 (39%) non-sustained VT. Heart transplantation was performed in 15 of 79 (19%) LMNA patients during 7.8 ± 6.3 years of follow-up. CONCLUSION: LMNA mutation prevalence was 6.2% of familial DCM in Norway. Cardiac penetrance was high in young asymptomatic LMNA genotype-positive family members with frequent AV block and VT, highlighting the importance of early family screening and cardiological follow-up. Nearly 20% of the LMNA patients required heart transplantation.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Hasselberg NE, Haland TF, Saberniak J, et al. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018. PMID: 29095976. doi:10.1093/eurheartj/ehx596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。